Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for injection/infusion - 5.0 milligram(s)/millilitre - amides; levobupivacaine

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for injection/infusion - 7.5 milligram(s)/millilitre - amides; levobupivacaine

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - glecaprevir 100mg;  ; pibrentasvir 40mg;   - film coated tablet - active: glecaprevir 100mg   pibrentasvir 40mg   excipient: colloidal silicon dioxide copovidone croscarmellose sodium hypromellose iron oxide red lactose monohydrate macrogol 3350 propylene glycol monocaprylate sodium stearyl fumarate titanium dioxide tocofersolan - maviret is indicated for the treatment of adults and adolescents 12 years and older with chronic hepatitis c virus (hcv)

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - levobupivacaine hydrochloride - solution for infusion - 0.625 milligram(s)/millilitre - amides; levobupivacaine

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - dexamethasone 700ug - intraocular implant - 700 mcg - active: dexamethasone 700ug excipient: polyglactin (poly (d, l-lactide-co-glycolide), 50:50 plga acid) polyglactin - ozurdex® is indicated for the treatment of macular oedema due to retinal vein occlusion (rvo).

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - ketorolac trometamol 5 mg/ml;  ;   - eye drops, solution - 0.5% w/v - active: ketorolac trometamol 5 mg/ml     excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid macrogols purified water sodium chloride sodium hydroxide

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - fluorometholone 1 mg/ml;   - eye drops, solution - 0.1% w/v - active: fluorometholone 1 mg/ml   excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 polyvinyl alcohol purified water sodium chloride sodium edetate sodium hydroxide

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - bimatoprost 0.3 mg/ml;  ; timolol maleate 6.8 mg/ml equivalent to 5 mg/ml timolol;   - eye drops, solution - active: bimatoprost 0.3 mg/ml   timolol maleate 6.8 mg/ml equivalent to 5 mg/ml timolol   excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - gentamicin sulfate 0.3%{relative} (10% overage added) - eye drops, solution - 0.3% w/w - active: gentamicin sulfate 0.3%{relative} (10% overage added) excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate disodium edetate dihydrate hydrochloric acid polyvinyl alcohol sodium chloride sodium hydroxide water for injection - the product is indicated in the topical treatment of infections of the external eye and its adnexa caused by susceptible bacteria. such infections include conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis and dacryocystitis.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - bimatoprost 0.3 mg/ml;   - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml   excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.